कृपया अन्य खोज का प्रयास करें
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing gene-based therapies for patients with cancer and diabetes in the United States. The company’s lead product candidate is REQORSA (GPX-001), which is in preclinical trials to treat non-small cell lung cancer and small cell lung cancer; and GPX-002, which is in preclinical trials to treat type 1 and type 2 diabetes. Its product pipeline comprises Acclaim-1, which is in phase 2a clinical trial for the treatment of non-small cell lung cancer; Acclaim-2, which is in phase phase 1/2 clinical trial for the treatment of non-small cell lung cancer; and Acclaim-3, which is in phase 1/2 clinical trial for the treatment of small cell lung cancer. The company also develops ONC-001, REQORSA as a monotherapy, which is in phase 1 clinical trial to treat advance non-small cell lung cancer; and ONC-002, REQORSA with Tarceva, which is in phase 2 clinical trial to treat non-small cell lung cancer. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Brent M. Longnecker | 68 | 2020 | Independent Director |
Shu Kam Mok | 64 | - | Member of Scientific & Medical Advisory Board |
Pasi Antero Janne | - | - | Member of Scientific & Medical Advisory Board |
George K. Gittes | - | 2020 | Member of Scientific Advisory Board |
George Simon | - | - | Member of Scientific & Medical Advisory Board |
James E. Rothman | 73 | 2012 | Strategic Advisor to the Board of Directors |
Jose Antonio Moreno Toscano | 51 | 2020 | Independent Director |
George E. Peoples | - | 2021 | Member of Clinical Advisory Board |
Michael Morse | - | 2021 | Member of Clinical Advisory Board |
William R. Wilson | 74 | 2020 | Independent Director |
Andrew B. Becker | - | 2021 | Member of Clinical Advisory Board |
Jack A. Roth | - | - | Chairman of Scientific & Medical Advisory Board |
Ryan M. Confer | 42 | 2016 | President, CEO, CFO & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है